In yet one other trial of cell treatment for heart failure, this time in most cancers survivors with anthracycline-triggered cardiomyopathy (AIC), administration of allogeneic bone…
In yet one other trial of cell treatment for heart failure, this time in most cancers survivors with anthracycline-triggered cardiomyopathy (AIC), administration of allogeneic bone…